info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Ascites Companies

Ascites companies are dedicated to addressing abdominal fluid accumulation in various medical conditions. Specializing in research and development, these companies provide innovative solutions for the management of ascites, offering healthcare providers effective tools to improve patient comfort and overall quality of life.

Ascites  key companies

 


Latest Ascites Companies Update:

BioVie This clinical-stage biopharmaceutical company is developing pegacrisantaspase, a novel enzyme-based therapy for the treatment of malignant ascites associated with ovarian cancer. BioVie recently announced positive interim results from its Phase 2b trial, demonstrating statistically significant reductions in ascitic fluid volume and improved quality of life for patients.


Noorik Biopharmaceuticals AG: This Swiss company is focusing on developing and commercializing therapeutic solutions for fluid overload conditions, including ascites. Their lead product, pegylated human hyaluronidase (PEGPH20), is currently in Phase 3 clinical trials for the treatment of malignant ascites associated with pancreatic cancer.


BD, B. Braun, Pfizer, and Medtronic are also involved in the Ascites market, offering various products for paracentesis, drainage, and other management procedures. These companies are continuously innovating and developing new technologies to improve patient outcomes.


List of Ascites Key companies in the market


  • Square Medical NV of Switzerland

  • BioVie Inc. of the US

  • PharmaCyte of US

  • Fresenius SE & Co. KGaA of Germany

  • BD of US

  • GI Supply of US

  • Medtronic of Ireland



Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.